ArticleThe Journal of investigative dermatology2012

AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.

Sojun Hoshimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.